에 대한 최신 뉴스 Bilibili (NASDAQ:BILI) 주식

Bilibili

Bilibili is a Chinese online entertainment platform that is best known for its video-sharing site that resembles YouTube. The site was founded in 2009 and started as a long-form video platform for anime, comics, and gaming, or ACG, content that appealed to Gen Z users. Since then, it has expanded its content on the platform to include a broader range of interests that have attracted Chinese users outside of the Gen Z cohort. The firm generates revenue through five main areas: advertising, games, live streaming, value-added services, and e-commerce.

Mid Cap

News

Movers

Trading Ideas

BILI

RKLB

XPEV

지난주, 중국 중앙은행이 은행의 지급준비율(RRR)을 50bp(베이시스 포인트) 또는 0.5%포인트 인하하기로 발표하면서 미국에 상장된 중국 기업들의 주가가 전반적으로 상승했다.

중국 주식이 우세 - 빌리빌리와 샤오펑은 지난주 최고 성과를 보여준 7개 중형주 중 일부 (9월 23일-9월 27일)

AMKR

BRFS

IBRX

IRTC

ITCI

OLLI

TALO

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 빌리빌리(NASDAQ:BILI)의 주가는 지난주 &#39;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#39; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 21달러 가격 목표를 발표했다. 

빌리빌리와 올리즈 바겐은 지난주 최대 성과를 보인 10개 중형주 중 일부 (6월 16일-6월 22일)

Bilibili Inc. - American Depositary Shares

Bilibili Inc

Bilia AB

The dust is beginning to settle from the 2024 election, and companies are starting to digest what a second Trump term means for business. On the campaign trail, Candidate Trump promised another round of tariffs on foreign goods, but it remains to be seen what promises actually translate into law once the administration comes to power.&nbsp;
Some companies like Steve Madden are attempting to get ahead of the curve by <a href="https://www.benzinga.com/24/11/41862692/steve-madden-announces-plans-to-move-production-to-avoid-trump-tariffs-but-theres-a-catch">moving production out of China now</a>, but others aren't as nimble and will likely bear the brunt of higher costs. Which public companies are likely to be hit hardest by tariff expansion? Here&#8217;s a list of 4 stocks you might want to consider selling before the next trade war salvo.
<h2 class="wp-block-heading">Methodology</h2>
Each company chosen for this list faces at least one of the following issues:
<ul>
<li>Reliance on imports, especially goods from China </li>
<li>Limited ability to pass higher costs onto customers </li>
<li>Lack of negotiating power with suppliers&nbsp;</li>
<li>Thin margins that could make it challenging to absorb costs </li>
</ul>
The retail industry is already bracing for higher costs. According to the National Retail Foundation, companies are preparing for these additional costs by raising prices on a variety of goods that could cost consumers between $46 billion and $76 billion in purchasing power. Retail will be a major theme amongst these stock picks, especially in areas where customers expect low prices and have substantial alternatives.
<h3 class="wp-block-heading">Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>)</h3>
Dell has been one of the market's biggest winners since the start of 2023. The company has re-entered the S&amp;P 500 and its stock price has soared from under $40 in March 2023 to over $130 as of this writing. The stock has pulled back a bit since hitting an all-time high of $179 in May, and more pain could be on the way if the proposed tariffs come to be.
Dell sells a variety of electronics, from computers and laptops to cloud and networking solutions. This line of electronics depends on affordable printed circuit boards (PCBs), capacitors, resistors, casings, and assembly operations, and much of this company infrastructure is located in China. Additional tariffs on these components could force Dell to either raise prices faster than customers see reasonable or relocate some of their production outside of China. Either solution could hamper future stock growth. Dell is currently rated a Buy, but the <a href="https://www.benzinga.com/quote/DELL/analyst-ratings">most recent analyst reports</a> put the consensus price target at $117, which is below the current market price.
<h3 class="wp-block-heading">Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>)</h3>
If you or your spouse are primary education teachers, you likely have spent a lot of time in Five Below looking for school supplies, affordable electronics, student rewards, and perhaps some candy for the lounge. The company sells a variety of merchandise at highly discounted prices, and many of its electronic products are imported from China.
Five Below gets hit from both sides in a potential tariff war. Not only is the company heavily reliant on Chinese imports, but its business model leaves very little room to raise prices. Customers who see higher prices at specialty retailers like Five Below may just take their business to higher-end competitors like Target Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>). Analysts currently rate FIVE stock as a Hold with an average price target of $129. However, the three most recent analyst reports (Truist, BofA Securities, and Evercore ISI) only had an average price target of $89, which is about where shares are currently trading. BofA analyst Lorraine Hutchinson <a href="https://www.cnbc.com/2024/11/06/trump-proposed-tariffs-consumer-prices.html">noted in her downgrade</a> that Five Below sources more than 20% of its products from China and lacks the pricing power to pass those costs onto consumers.
<h3 class="wp-block-heading">Lowe's Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>)</h3>
Another big winner from the past two years could be facing more headwinds if tariffs come to fruition. Lowe's has benefited from the home price boom as millions of Americans tapped their expanding home equity for upgrades and renovations following COVID. LOW shares shot from a pandemic low of $86 to $258 by December 2021 and recently made a new all-time high at $270 a few weeks ago. However, if we use history as a guide, Lowe's stock had a choppy ride during the first round of tariffs in 2017.
Lowe's sells high-end appliances like washing machines, dryers, refrigerators, water heaters, and other important (and imported) home goods. Not only will the company face higher costs on these expensive goods, but consumers who have already tapped chunks of home equity may put off new projects or rush to buy before the tariffs kick in. From 2017 to 2020, LOW shares exhibited high volatility with four different 15% corrections. With more tariffs on tap and consumers stretched thin, Lowe's profits could take a hit in the coming months. The company reports earnings on November 19 and investors will be looking for clues on how tariffs could affect its bottom line.
<h3 class="wp-block-heading">Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>)</h3>
Another stock up big this year, and another company under pressure from the incoming administration. Walmart didn't suffer as much as the broader indices during the 2022 bear market, but the stock has roared to life in 2024. WMT shares are up over 60% year-to-date, including an eye-popping 41% in the last six months. The company has beaten analyst earnings expectations in each of the previous eight quarters as well.
In recent years, Walmart has sought to divest itself from China by moving some production to India, but Chinese imports still make up <a href="https://www.reuters.com/business/retail-consumer/walmart-shifts-india-china-cheaper-imports-2023-11-29/">about 60%</a> of the company's products. It's unlikely that much more production will be moved out of China by the time tariffs take effect, and Walmart doesn't have the supplier negotiating power that a company like Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) does. Additionally, Walmart's Every Day Low Price model runs on razor-thin margins. In July, Walmart reported a <a href="https://www.macrotrends.net/stocks/charts/WMT/walmart/net-profit-margin">net profit margin of 2.34%</a>. While not as low as some previous reports, Walmart has consistently seen its net margin drop below 3% since the first Trump administration, and the company may not have the pricing power to pass additional tariff costs onto its customers.
Take the guesswork out of investing with a handpicked portfolio of value stocks that consistently outperforms the S&amp;P 500. Invest in a proven, time-tested selection designed for long-term growth. <a href="https://www.benzinga.com/premium/ideas/perfect-portfolio/?utm_source=RD-1115">Click to get access now.</a>
Image via Shutterstock

Opinion

COST

DELL

FIVE

4 Stocks to Sell Before Trump's Tariffs Take Effect

Needham analyst Laura Martin maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and raises the price target from $8.5 to $9.5.

Price Target

Analyst Ratings

NEXN

Needham Maintains Buy on Nexxen International, Raises Price Target to $9.5

In the current session, Aptiv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) is trading at $53.09, after a 1.73% decrease. Over the past month, the stock decreased by 25.95%, and in the past year, by 34.77%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1731699923_0.png" alt="Past Year Chart" />

<h3>Comparing Aptiv P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Aptiv has a lower P/E than the aggregate P/E of 28.77 of the Automobile Components industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1731699923_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

APTV

Price Over Earnings Overview: Aptiv

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) with a Buy and maintains $33 price target.

Reiteration

PPBT

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target

Rumors

Legal

JNPR

Watching Juniper Networks; Shares Move Lower As Traders Circulate Research Report Suggesting DOJ Examining Depositions Of Hewlett Packard Enterprise And Juniper Networks' Executives And Third-Party CID Responses, Preparing To Decide Case As Early As Next Week

<h3 class="wp-block-heading">Weed Is Not Legal In Florida But Medical Cannabis Retail Footprint Grows Nonetheless</h3>
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new West Orlando location expanded RISE Dispensaries' retail footprint in Florida to 21 locations and 99 nationwide.
Cannabis giant Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) opened a new medical dispensary in Miami in October. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd. in Miami, brought the company's Florida store count to 66 locations, with 151 dispensaries total nationwide.
Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>), one of the biggest supporters of Amendment 3 which was rejected by Florida voters earlier this month and would have legalized recreational cannabis in the Sunshine State, additionally expanded its already substantial retail footprint statewide.
October store opening celebrations were held at:
<ul>
<li>Trulieve Bonita Springs South Tamiami, located at 28811 South Tamiami Trail, Unit 12, and Trulieve St. Augustine A1A, located at 3945 A1A South on Oct. 18;</li>
<li>Trulieve Orlando West Colonial, located at 7225 West Colonial Drive, Unit 100 on Oct. 25; and</li>
<li>Trulieve Lake Placid, located at 413 U.S. Highway 27, on Nov. 1.</li>
</ul>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">New Cannabis Stores In Six States And Canada</h3>
Illinois cannabis sales reached a major milestone in July, with sales surpassing $1 billion, as announced by Governor JB Pritzker‘s office. The burgeoning industry continues to grow by the day with new stores launching cannabis sales and events celebrating the plant. Stash Dispensaries recently announced the return of&nbsp;Sesh Haunted City, a special haunted house event to commemorate Sesh&#8217;s third anniversary.
C3 Industries, a multi-state cannabis company dedicated to crafting premium consumer experiences, recently opened High Profile Cannabis Shop Pineville at 35 Macadoodle Lane, its 9th retail location in Missouri and 29th nationwide.
Cannabis concept store Gotham held a grand opening event in October for its new Brooklyn, New York City location. The expansive 4,000-square-foot storefront is located in the heart of Williamsburg on Kent Avenue and South 2nd Street in The Refinery at Domino.
Sweetspot Farms, a new premium cannabis dispensary, is officially open at 111 High Ridge Rd. in Stamford, Connecticut, offering medical and recreational customers a modern and welcoming retail experience. Founded by two Stamford natives, Sweetspot aims to improve access to legal and regulated cannabis for qualified locals who depend on plant-based products for an improved quality of life.
SLO CAL Roots celebrated the grand opening of its third dispensary, Root One, in Guadalupe, California in October. Root One is the latest location from SLO CAL Roots, a Central Coast cannabis company founded in 2003 by local growers Austen Connella and Kristin Kordich.
Hashstoria, a cannabis dispensary co-founded by hip-hop icon Raekwon the Chef of Wu-Tang Clan fame, media personality Charlamagne Tha God, civil rights attorney Bakari Sellers and entrepreneur Jedd Canty hosted the official grand opening celebration in downtown Newark, New Jersey on Wednesday, Nov. 13. It's located at 799-805 Broad Street in the historic Four Corners district.
High Tide Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HITI#TSXV">HITI</a>) (FSE: 2LYA) Canna Cabana retail cannabis store, located at 97 Bath Road, Kingston, Ontario, began selling recreational cannabis products and consumption accessories for adult use on Oct. 31. This opening marked the 186th Canna Cabana branded retail cannabis location in Canada, the 72nd in the province of Ontario, and the first in Kingston for the Canadian retail cannabis giant.

Cannabis

Entrepreneurship

Retail Sales

CSE:GTII

CSE:TRUL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

GTII

HITI

TCNNF

TRUL

TSX:CURA

TSXV:HITI

Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores

Needham analyst Laura Martin maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $110 to $130.

Needham Maintains Buy on Walt Disney, Raises Price Target to $130

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPX#NASDAQ">CMPX</a>) with a Buy and maintains $10 price target.

CMPX

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target

HC Wainwright &amp; Co. analyst Ed Arce reiterates Sagimet Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMT#NASDAQ">SGMT</a>) with a Buy and maintains $32 price target.

SGMT

HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $32 Price Target

HC Wainwright &amp; Co. analyst Yi Chen reiterates Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) with a Buy and maintains $15 price target.

KALA

HC Wainwright & Co. Reiterates Buy on Kala Bio, Maintains $15 Price Target

Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) has outperformed the market over the past 15 years by 2.32% on an annualized basis producing an average annual return of 14.04%. Currently, Keurig Dr Pepper has a market capitalization of $45.06 billion. 
Buying $1000 In KDP: If an investor had bought $1000 of KDP stock 15 years ago, it would be worth $7,196.06 today based on a price of $33.22 for KDP at the time of writing.
<h3>Keurig Dr Pepper's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699205_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Keurig Dr Pepper 15 Years Ago Would Be Worth This Much Today

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 6.46% on an annualized basis producing an average annual return of 17.48%. Currently, HCA Healthcare has a market capitalization of $87.70 billion. 
Buying $100 In HCA: If an investor had bought $100 of HCA stock 10 years ago, it would be worth $506.91 today based on a price of $339.83 for HCA at the time of writing.
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699201_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today

Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) has outperformed the market over the past 10 years by 18.87% on an annualized basis producing an average annual return of 29.89%. Currently, Fabrinet has a market capitalization of $9.04 billion. 
Buying $1000 In FN: If an investor had bought $1000 of FN stock 10 years ago, it would be worth $13,993.98 today based on a price of $249.31 for FN at the time of writing.
<h3>Fabrinet's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699196_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Fabrinet Stock In The Last 10 Years

First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) has outperformed the market over the past 20 years by 6.83% on an annualized basis producing an average annual return of 15.15%. Currently, First Citizens BancShares has a market capitalization of $30.11 billion. 
Buying $100 In FCNCA: If an investor had bought $100 of FCNCA stock 20 years ago, it would be worth $1,728.18 today based on a price of $2152.02 for FCNCA at the time of writing.
<h3>First Citizens BancShares's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699191_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCNCA

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,700 Today

HC Wainwright &amp; Co. analyst Edward White reiterates 60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) with a Neutral.

SXTP

HC Wainwright & Co. Reiterates Neutral on 60 Degrees

Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) has outperformed the market over the past 15 years by 1.85% on an annualized basis producing an average annual return of 13.57%. Currently, Johnson Controls Intl has a market capitalization of $56.41 billion. 
Buying $100 In JCI: If an investor had bought $100 of JCI stock 15 years ago, it would be worth $684.45 today based on a price of $84.45 for JCI at the time of writing.
<h3>Johnson Controls Intl's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699187_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth This Much Today

Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) has outperformed the market over the past 20 years by 1.26% on an annualized basis producing an average annual return of 9.59%. Currently, Crown Castle has a market capitalization of $44.95 billion. 
Buying $1000 In CCI: If an investor had bought $1000 of CCI stock 20 years ago, it would be worth $6,268.48 today based on a price of $103.43 for CCI at the time of writing.
<h3>Crown Castle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699182_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Crown Castle Stock In The Last 20 Years

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 20 years by 2.84% on an annualized basis producing an average annual return of 11.16%. Currently, Texas Instruments has a market capitalization of $184.14 billion. 
Buying $100 In TXN: If an investor had bought $100 of TXN stock 20 years ago, it would be worth $822.22 today based on a price of $201.85 for TXN at the time of writing.
<h3>Texas Instruments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699176_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Texas Instruments 20 Years Ago Would Be Worth This Much Today

Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) has outperformed the market over the past 15 years by 15.86% on an annualized basis producing an average annual return of 27.59%. Currently, Comfort Systems USA has a market capitalization of $15.82 billion. 
Buying $1000 In FIX: If an investor had bought $1000 of FIX stock 15 years ago, it would be worth $40,251.81 today based on a price of $444.38 for FIX at the time of writing.
<h3>Comfort Systems USA's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699171_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Comfort Systems USA 15 Years Ago Would Be Worth Today

CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) has outperformed the market over the past 5 years by 8.02% on an annualized basis producing an average annual return of 21.4%. Currently, CRH has a market capitalization of $66.88 billion. 
Buying $1000 In CRH: If an investor had bought $1000 of CRH stock 5 years ago, it would be worth $2,673.92 today based on a price of $98.52 for CRH at the time of writing.
<h3>CRH's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731699167_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER – Tapestry&nbsp;(TPR) up 8% after announcing the mutual te...

Morning Movers: Disney jumps following Q4 earnings

Bilibili Inc. 2024 Q3 - Results - Earnings Call Presentation

Bilibili Inc. (BILI) Q3 2024 Earnings Call Transcript

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Disney (DIS) reported better-than-expe...

Disney reports Q4 beat, Capri-Tapestry call off deal: Morning Buzz

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Bilibili (NASDAQ:<a href="https://investorplace.com/stock-quotes/bili-stock-quote/">BILI</a>) just reported results for the second quarter of 2024.<ul><li>Bilibili reported earnings per share of -9 cents. This was above the analyst estimate for EPS of -11 cents.</li><li>The company reported revenue of $843.10 million.</li><li>This was 0.71% better than the analyst estimate for revenue of $837.17 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/bili-stock-earnings-bilibili-for-q2-of-2024/">BILI Stock Earnings: Bilibili Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BILI Stock Earnings: Bilibili Beats EPS, Beats Revenue for Q2 2024

Bilibili ( ($BILI) ) has released its Q3 earnings. Here is a breakdown of the information Bilibili presented to its investors. Bilibili Inc. is a l...

Bilibili Inc. Reports Strong Q3 2024 Growth

Bilibili (BILI – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst yesterday. Analyst Brian Gong ...

Bilibili: Hold Rating Maintained Amid Fair Valuation and Steady Growth Prospects

Bilibili (BILI – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst today. Analyst Saiyi HE from C...

Bilibili Gains Buy Rating Amid Strong Revenue Growth and Strategic Initiatives

In a report released today, Fawne Jiang from Benchmark Co. maintained a Buy rating on Bilibili (BILI – Research Report), with a price target of $24...

Benchmark Co. Reaffirms Their Buy Rating on Bilibili (BILI)

Benchmark raised the firm's price target on Bilibili (BILI) to $24 from $16 and keeps a Buy rating on the shares after the company reported "strong...

Bilibili price target raised to $24 from $16 at Benchmark

AAPL

AMZN

BLBLF

BLNK

BRAG

CBRL

CPRI

CRKN

CSCO

FPAY

GAMB

HIMS

HNHAF

HNHPF

MDXG

NCSYF

NICE

NVDA

OMER

PLUG

PZZA

SFTBF

SFTBY

SPOT

Press Releases

Bilibili Inc. to Hold Annual General Meeting on June 28, 2024

Bilibili Inc. to Report First Quarter 2024 Financial Results on Thursday, May 23, 2024

Earnings

Bilibili Inc. Announces First Quarter 2024 Financial Results

Qiming's Nisa Leung Made the 2024 Forbes Midas List

Bilibili Inc. Announces Results of Annual General Meeting

Bilibili Inc. to Report Second Quarter 2024 Financial Results on Thursday, August 22, 2024

Bilibili Inc. Announces Second Quarter 2024 Financial Results

Bilibili Inc. Announces Repurchase Right Notification for 0.50% Convertible Senior Notes due 2026

Bilibili Inc. to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Bilibili Inc. Announces Third Quarter 2024 Financial Results

GPCR

SDGR

ZLAB

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Autohome

Baidu, Inc. - American Depositary Shares, each representing 8 ordinary share

Baidu

KANZHUN LIMITED - American Depository Shares

Kanzhun

CarGurus

Trump Media & Technology Group Corp. - Common Stock

Trump Media & Technology

Trump Media & Technology Group Corp. - Warrants

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings

Alphabet

Grindr

Hello Group Inc. - American Depositary Shares

Hello Gr

Match Group

Pinterest

Reddit

Rumble

Snap

Tripadvisor

Weibo Corporation - American Depositary Shares

Weibo

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yelp

JOYY

Ziff Davis

ZoomInfo Technologies Inc. - Common Stock

ZoomInfo Technologies

Benchmark

Mizuho

B of A Securities

Bernstein

Barclays

지난주, 중국 중앙은행이 은행의 지급준비율(RRR)을 50bp(베이시스 포인트) 또는 0.5%포인트 인하하기로 발표하면서 미국에 상장된 중국 기업들의 <a href="https://www.benzinga.com//node/41065178" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가가 전반적으로</a> 상승했다.
이 7개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 루팍스 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>)의 주식이 23.48% 상승했다.
2. 빌리빌리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>)의 주식이 32.47% 급등했다. 이는 중국이 2,840억 달러까지의 국채를 발행할 것이라는 보도가 나온 후 계속된 강세 때문으로 보인다.
3. 칸준(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>)의 주식이 26.63% 상승했다.
4. TAL 에듀케이션 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>)의 주식이 27.23% 급등했다. 이는 중국 인민은행(PBoC)의 공격적인 통화 부양책 덕분이다.
5. 샤오펑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>)의 주식이 32.50% 상승했다. 이는 중국이 2,840억 달러 규모의 국채를 발행할 것이라는 보도가 나온 후의 계속된 강세 때문이다.
6. MP 머티리얼즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>)의 주식이 32.40% 상승했다. 이는 메리츠가 주식의 목표 주가를 20달러에서 25달러로 상향 조정한 후 발생한 일이다.
7. 로켓 랩 USA(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)의 주식이 30.92% 상승했다. 이는 여러 애널리스트들이 목표 주가를 올린 후 발생한 일이다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A6%AC%EC%A0%9C%EB%84%A4%EB%A1%A0%EA%B3%BC-%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC%EB%A5%BC/" target="_blank" rel="noopener">리제네론과 슈퍼 마이크로는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 23일-9월 27일)</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%A4%91%EA%B5%AD-%EC%A3%BC%EC%8B%9D-%EC%9A%B0%EC%84%B8-jd%EB%8B%B7%EC%BB%B4%EA%B3%BC-pdd%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC/" target="_blank" rel="noopener">중국 주식 우세 – JD닷컴과 PDD는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (9월 23일-9월 27일)</a></li>
</ul>
이미지 제공: Robert Way via Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>빌리빌리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>)의 주가는 지난주 &#8216;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#8217; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 <a href="https://www.benzinga.com//node/39418621" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">21</a>달러 가격 목표를 발표했다.</li>
<li>이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)의 주가는 안크티바(ANKTIVA)가 여러 주에 걸쳐 <a href="https://www.benzinga.com//node/39417764" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">첫 번째 상용 투여량</a>을 투여한 보험 적용 범위를 발표한 이후 지속적인 강세로 22.36% 상승했다.</li>
<li>사솔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>)은 회사가 법원에서 회사와 토탈에너지스 SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) 마켓팅에 유리한 판결을 내렸다고 발표한 후 주가는 20.89% 상승했다. 또한 손해배상금으로 38.9억 랜드, <a href="https://www.benzinga.com//node/39412202" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">이자로 약 2,300만 랜드</a>를 받았다.</li>
<li>지난주 올리즈 바겐 아울렛 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>)의 주식은 JP모건이 중립에서 <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">비중확대</a>로 평가를 올린 이후 15.25% 상승했다.</li>
<li>인트라-셀룰러 테라피스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>)는 회사가 루마테페론을 주요 우울 장애 환자를 위한 보조 요법으로 평가하고 <a href="https://www.benzinga.com//node/39382029" target="_blank" rel="noreferrer noopener">1차 및 주요 2차 평가변수를 충족</a>시키는 두 번째 3상 시험의 톱라인 결과를 발표한 후 주가는 13.18% 상승했다.      shares advanced 12.06% on overall strength in chip stocks. Also, B. Riley Securities analyst <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">raised the price forecast</a> on the stock from $45 to $50.</li>
<li>앰코 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>)는 전반적인 칩주 강세로 주가는 12.06% 상승했다. 또한 B. 라일리 증권(B. Riley Securities)의 분석가는 주식 가격 <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">예측</a>을 45달러에서 50달러로 높였다.</li>
<li>아이리듬 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>)는 회사가 이전에 공개한 <a href="https://www.benzinga.com//node/39411935" target="_blank" rel="noreferrer noopener">제조 자동화 계획</a>의 초기 단계를 시작한 후 기업의 이정표에 도달했다고 발표한 후 주가는 11.53% 증가했다.</li>
<li>로켓 랩 USA(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)는 주가는 <a href="https://www.benzinga.com//node/39429411" target="_blank" rel="noreferrer noopener">일본 기업 신스펙티브(Synspective)</a>와 도쿄에서 10개 제품 출시 계약을 체결한 후 11.32% 상승했다.</li>
<li>브레드 파이낸셜 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>)는 에버코어 ISI 그룹(Evercore ISI Group)이 이 주식을 언더퍼폼(Underperform)에서 인-라인(In-Line)으로 평가를 올리고 목표 주가를 42달러에서 45달러로 <a href="https://www.benzinga.com/quote/BFH/analyst-ratings" target="_blank" rel="noreferrer noopener">상향 조정한 </a>이후 10.81% 상승했다. 또한 또한 RBC 캐피털은 해당 주식에 대해 섹터 퍼폼(Sector Perform) 등급을 유지하고 목표 주가를 38달러에서 45달러로 높였다.</li>
<li>BRF S.A.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>)의 주식은 10.69% 상승했다.</li>
</ol>
위키미디어 커먼즈를 통한 사진
기사 읽기: <a href="https://kr.benzinga.com/news/%ea%b2%8c%ec%9e%84%ec%8a%a4%ed%83%91%ea%b3%bc-%ec%9e%90%eb%b9%8c%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%ea%b0%9c%ec%9d%98/" target="_blank" rel="noopener">게임스탑과 자빌은 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)</a>

Comments

Bilibili

뉴스

에 대한 최신 뉴스 Bilibili (NASDAQ:BILI) 주식

월요일, 9월 30, 2024

월요일, 6월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌